ceribell.comHealthcare / Medical DevicesFounded: 2014Funding to Date: $306.52MM
Ceribell is the developer of a highly innovative electroencephalography (EEG) device, designed to make the diagnosis of neurological patients drastically more efficient.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/22/2022 | Series C-NV | $2.8MM | $xx.xx | $326.5MM | Ally Bridge Group, Longitude Capital, Ra Capital Management, Redmile Group, Red Tree Venture Capital, The Rise Fund | |
Price per Share
$xx.xx
Shares Outstanding
626,398
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ally Bridge Group, Longitude Capital, Ra Capital Management, Redmile Group, Red Tree Venture Capital, The Rise Fund
|
||||||
09/22/2022 | Series C-1 | $99.89MM | $xx.xx | $326.5MM | Ally Bridge Group, Longitude Capital, Ra Capital Management, Redmile Group, Red Tree Venture Capital, The Rise Fund | |
Price per Share
$xx.xx
Shares Outstanding
22,347,373
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Ally Bridge Group, Longitude Capital, Ra Capital Management, Redmile Group, Red Tree Venture Capital, The Rise Fund
|
||||||
09/25/2018 | Series B | $36.08MM | $xx.xx | $124.68MM | Livanova, Optimas Capital Partners Fund, The Rise Fund, Ucb | |
Price per Share
$xx.xx
Shares Outstanding
12,115,096
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Livanova, Optimas Capital Partners Fund, The Rise Fund, Ucb
|
||||||
05/03/2017 | Series A | $13.49MM | $xx.xx | $42.04MM | Dhvc, Shangbay Capital | |
Price per Share
$xx.xx
Shares Outstanding
7,778,774
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Dhvc, Shangbay Capital
|
||||||
08/31/2015 | Series Seed | $999,999.12 | $xx.xx | $5MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,130,799
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
0.0%
Cumulative
Non-cumulative
Participating
Participating
Participation Cap
1000
Key Investors
Undisclosed Investors
|